Ivermaxx 24 mg

For a confirmed infection caused by an ivermectin-sensitive parasite, treatment can:

• Reduce the number of susceptible parasites

• Support clearance of certain intestinal infections

• Relieve symptoms linked to parasite activity

• Control selected parasite-related skin conditions

• Reduce the risk of complications from an untreated infection

• Provide a fixed dose when 24 mg matches the calculated amount

Some infections require follow-up examinations or laboratory tests to confirm that the parasites have cleared. Continuing symptoms should be assessed before another dose is taken.

Ongoing COVID-19 and cancer studies can improve scientific understanding of ivermectin. They have not confirmed treatment benefits from Ivermaxx 24 mg for either condition.

Ivermectin binds to glutamate-gated chloride channels in the nerve and muscle cells of susceptible parasites. This causes more chloride ions to enter the cells and disrupts normal nerve activity.

The parasites lose control of their muscles, become paralysed and die or are gradually removed from the body. The medicine only works against parasites that are sensitive to ivermectin.

Laboratory researchers have also studied ivermectin’s effects on cellular signalling, immune activity and cancer-cell survival. Laboratory findings cannot establish a safe or effective treatment in people without properly controlled human trials.

Ivermaxx 24 mg dosage depends on body weight, the diagnosed parasite, medical history and the treatment plan. The complete tablet should be taken only when 24 mg matches the calculated dose.

For strongyloidiasis, prescribing references commonly use approximately 200 micrograms of ivermectin per kilogram of body weight as a single oral dose. For onchocerciasis, approximately 150 micrograms per kilogram is commonly used. These figures explain standard weight-based calculations and are not instructions for self-treatment.

Take the prescribed dose with water. Many oral ivermectin labels recommend taking it on an empty stomach. Follow-up testing or a repeat dose is required for certain infections.

If the calculated amount differs from 24 mg, the healthcare professional can select another tablet strength or combination. Do not round the dose upward or divide the tablet unless clear instructions are provided.

There is no established Ivermaxx 24 mg dosage for COVID-19 or cancer, as the clinical trials are still ongoing. Doses used in research studies should not be copied outside the trial setting.

Common Side Effects: Ivermaxx 24 mg can cause nausea, diarrhoea, stomach discomfort, reduced appetite, dizziness, headache, tiredness, itching or a mild skin rash. Fever, muscle pain, tender lymph nodes or temporary worsening of skin symptoms can occur as the body reacts to dying parasites. Speak with a healthcare professional if these effects continue or become difficult to manage.

Serious Side Effects: Seek immediate medical help for breathing difficulty, facial or throat swelling, severe or blistering skin reactions, fainting, seizures, confusion, difficulty walking, unusual drowsiness, major vision changes or yellow skin or eyes. People carrying a heavy Loa loa parasite load face a greater risk of serious neurological reactions following ivermectin treatment.

Ivermaxx 24 mg requires medical assessment for:

• People allergic to ivermectin

• Children weighing below 15 kg

• Pregnant or breastfeeding women

• People with significant liver problems

• People at risk of Loa loa infection

• People taking warfarin

• People using strong sedatives

• People receiving cancer treatment

• People considering COVID-19 self-treatment

• People considering cancer self-treatment

Tell the healthcare professional about every medicine, supplement and herbal product being used.

Important interactions requiring review include:

• Warfarin and other anticoagulants

• Sedatives and sleeping medicines

• Certain antifungal medicines

• Macrolide antibiotics

• HIV protease inhibitors

• Anti-seizure medicines

• Other ivermectin products

• Chemotherapy and immunotherapy

Warfarin users can require additional blood-clotting tests. Combining ivermectin with other treatments can also change its effects or increase side-effect risks.

• Keep the tablets in their original strip.

• Follow the storage temperature printed on the pack.

• Store in a cool and dry place.

• Protect from heat, moisture and sunlight.

• Keep out of reach of children and pets.

• Do not use tablets from damaged packaging.

• Check the batch number and expiry date.

• Dispose of expired tablets according to local guidance.